← Insider buys
KITE

Kite Pharma, Inc.

EVP, Business Development Helen Susan Kim sold $3.4M of Kite Pharma, Inc.

Sold$3,409,411
$67.78Price
50,300Shares
−73%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Tue, Feb 28. Filed Thu, Mar 2, 1:05 AM ET, before the open. Not investment advice.